Efficacy of vaginal cleansing in Cesarean Delivery
Phase 3
Recruiting
- Conditions
- O86.0Condition 1: postoperative infection after Cesarean Delivery such as:endometritis. Condition 2: postoperative infection after Cesarean Delivery such as:wound infection.Infection of obstetric surgical wound
- Registration Number
- IRCT20240713062414N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 205
Inclusion Criteria
All woman with cesarean indications
Obtaining informed consent to enter the study
Exclusion Criteria
Women with chorioamnionitis
Allergy for povidon iodine
Vaginal bleeding from placenta previa
Active genital herpes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie postoperative endometritis after Cesarean Delivery?
How does vaginal cleansing compare to standard-of-care antiseptics in preventing surgical site infections?
Are there specific biomarkers that identify patients at high risk for post-Cesarean wound infections?
What are the potential adverse events associated with vaginal cleansing protocols in postpartum care?
What combination therapies are being explored alongside vaginal cleansing to reduce post-Cesarean infections?